Showing 3251-3260 of 21432 results for "".
- Intermittent Fasting Shows Promise for Improving Metabolic Health in U.S. Adultshttps://reachmd.com/news/intermittent-fasting-shows-promise-for-improving-metabolic-health-in-us-adults/2468421/A clinical trial from the Salk Institute and the University of California San Diego School of Medicine offers promising insights into the potential of intermittent fasting, or time-restricted eating (TRE), to combat metabolic syndrome. With over one-third of American adults affected by metabolic
- Greater Calcium Burden Linked to Lower Vascular Inflammation, Study Findshttps://reachmd.com/news/greater-calcium-burden-linked-to-lower-vascular-inflammation-study-finds/2468438/A new study published in the Journal of the American College of Cardiology suggests that higher levels of coronary artery calcium are associated with reduced vascular inflammation and decreased plaque vulnerability. These findings may signal that heavily calcified plaques, often consider
- New Cardiovascular Risk Marker Identified in Older Womenhttps://reachmd.com/news/new-cardiovascular-risk-marker-identified-in-older-women/2468440/Researchers at Karolinska Institutet have uncovered a potential new marker for predicting cardiovascular disease risk in older women. In a study recently published in the Journal of the American College of Cardiology, they found that low levels of an anti-inflammatory antibody, known as
- NF-κB Pathway Found Crucial for X Chromosome Inactivation in Female T Cellshttps://reachmd.com/news/nf-b-pathway-found-crucial-for-x-chromosome-inactivation-in-female-t-cells/2468418/Researchers at the University of Pennsylvania have uncovered a critical link between the NF-κB signaling pathway and the maintenance of X chromosome inactivation in T cells, shedding new light on sex-based differences in immune responses. The study, published in Science Immunology, conne
- New Research Identifies Early Markers for Rheumatoid Arthritis, Opening Doors for Personalized Treatmenthttps://reachmd.com/news/new-research-identifies-early-markers-for-rheumatoid-arthritis-opening-doors-for-personalized-treatment/2468411/A recent study from Trinity College Dublin offers new insights into rheumatoid arthritis (RA), identifying key cellular markers that may allow for earlier diagnosis and more targeted treatments. Published in Science Advances, the findings could help clinicians better predict disease prog
- Rheumatoid Arthritis Study IDs Macrophages That Could Hasten Diagnosis, Treatmenthttps://reachmd.com/news/rheumatoid-arthritis-study-ids-macrophages-that-could-hasten-diagnosis-treatment/2468412/The results of research by scientists at Trinity College Dublin and St. Vincent’s University Hospital offer new insights into the cellular and genetic features of joint inflammation in rheumatoid arthritis (RA), which could point to new therapeutic approaches and the identification of
- UC Researcher Studies the Impact of Socio-Ecological Factors on Children's Sleephttps://reachmd.com/news/uc-researcher-studies-the-impact-of-socio-ecological-factors-on-childrens-sleep/2468387/Bridging the Center for the Silicon Heartland with Silicon ValleyAt the University of Cincinnati’s 1819 Innovation Hub, a suite consistently buzzes with student activity and spirited discussions. The room is occupied by UC’s NEXT Innovation Scholars (NIS) program, where rising st
- Are Ideas Contagious? How the Structure of Human-Interaction Networks Affects Spread of Both Illness & Informationhttps://reachmd.com/news/are-ideas-contagious-how-the-structure-of-human-interaction-networks-affects-spread-of-both-illness-information/2468388/Overview of the problem. (a) A contagion spreads on a network for 𝑇 time steps, and we observe the resulting sequence of states 𝑿. The probability that a susceptible node (white) becomes inf
- Analysis: Higher Infection and Acne Risks with JAK Inhibitors in ADhttps://reachmd.com/news/analysis-higher-infection-and-acne-risks-jak-inhibitors-ad/2468381/Researchers for a new analysis have provided a data and analytics framework for the evaluation of the safety of immune-modulating drugs (IMDs) in treating atopic dermatitis (AD). The study authors designed the system to generate timely, high-quality evidence using sequential propensity sco
- FDA Fast-Tracks Sublingual Therapy for Acute Ischemic Stroke Following Promising Trial Resultshttps://reachmd.com/news/fda-grants-breakthrough-therapy-designation-to-sublingual-treatment-for-acute-ischemic-stroke/2468360/The FDA has granted Breakthrough Therapy designation to Sanbexin, a sublingual tablet containing edaravone and dexborneol, for the treatment of acute ischemic stroke (AIS). This decision comes in light of strong data from the TASTE-SL phase 3 clinical trial, where Sanbexin demonstrated a signific